Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 24, 2026.

Multiple Roles of Chitosan in Mucosal Drug Delivery: An Updated Review

Paola Mura, Francesca Maestrelli, Marzia Cirri and 1 more

Marine Drugs · 2022 · Review · CC BY

doi:10.3390/md20050335

Abstract

Chitosan (CS) is a linear polysaccharide obtained by the deacetylation of chitin, which, after cellulose, is the second biopolymer most abundant in nature, being the primary component of the exoskeleton of crustaceans and insects. Since joining the pharmaceutical field, in the early 1990s, CS attracted great interest, which has constantly increased over the years, due to its several beneficial and favorable features, including large availability, biocompatibility, biodegradability, non-toxicity, simplicity of chemical modifications, mucoadhesion and permeation enhancer power, joined to its capability of forming films, hydrogels and micro- and nanoparticles. Moreover, its cationic character, which renders it unique among biodegradable polymers, is responsible for the ability of CS to strongly interact with different types of molecules and for its intrinsic antimicrobial, anti-inflammatory and hemostatic activities. However, its pH-dependent solubility and susceptibility to ions presence may represent serious drawbacks and require suitable strategies to be overcome. Presently, CS and its derivatives are widely investigated for a great variety of pharmaceutical applications, particularly in drug delivery. Among the alternative routes to overcome the problems related to the classic oral drug administration, the mucosal route is becoming the favorite non-invasive delivery pathway. This review aims to provide an updated overview of the applications of CS and its derivatives in novel formulations intended for different methods of mucosal drug delivery.

References 337

  1. 1.

    Song Y., Wang Y., Thakur R., Meidan V.M., Michniak B. Mucosal Drug Delivery: Membranes, Methodologies, and Applications. Crit. Rev. Ther. Drug Carrier Syst. 2004;21:195-256.

    Not in our library10.1615/critrevtherdrugcarriersyst.v21.i3.20

  2. 2.

    Mathias N.R., Hussain M.A. Non-Invasive Systemic Drug Delivery: Developability Considerations for Alternate Routes of Administration. J. Pharm. Sci. 2010;99:1-20.

    Not in our library10.1002/jps.21793

  3. 3.

    Goyal A.K., Singh R., Chauhan G., Rath G. Non-Invasive Systemic Drug Delivery through Mucosal Routes. Artif. Cells Nanomed. Biotechnol. 2018;46:539-551.

    Not in our library10.1080/21691401.2018.1463230

  4. 4.

    Abhang P., Momin M., Inamdar M., Kar S. Transmucosal Drug Delivery- An Overview. Drug Deliv. Lett. 2014;4:26-37.

    Not in our library10.2174/22103031113039990011

  5. 5.

    Liu J., Leng P., Liu Y. Oral Drug Delivery with Nanoparticles into the Gastrointestinal Mucosa. Fundam. Clin. Pharmacol. 2021;35:86-96.

    Not in our library10.1111/fcp.12594

  6. 6.

    Roy S., Prabhakar B. Bioadhesive Polymeric Platforms for Transmucosal Drug Delivery Systems—A Review. Trop. J. Pharm. Res. 2010;9:2043.

    Not in our library10.4314/tjpr.v9i1.52043

  7. 7.

    Mansuri S., Kesharwani P., Jain K., Tekade R.K., Jain N.K. Mucoadhesion: A Promising Approach in Drug Delivery System. React. Funct. Polym. 2016;100:151-172.

    Not in our library10.1016/j.reactfunctpolym.2016.01.011

  8. 8.

    Mahajan P., Kaur A., Aggarwal G., Harikumar S.L. Mucoadhesive Drug Delivery System: A Review. Int. J. Drug Dev. Res. 2013;5:11-20.

    Not in our library10.20959/wjpps20174-8863

  9. 9.

    Laffleur F. Mucoadhesive Polymers for Buccal Drug Delivery. Drug Dev. Ind. Pharm. 2014;40:591-598.

    Not in our library10.3109/03639045.2014.892959

  10. 10.

    Bonferoni M.C., Sandri G., Rossi S., Ferrari F., Caramella C. Chitosan and Its Salts for Mucosal and Transmucosal Delivery. Expert Opin. Drug Deliv. 2009;6:923-939.

    Not in our library10.1517/17425240903114142

  11. 11.

    Kumar A., Vimal A., Kumar A. Why Chitosan? From Properties to Perspective of Mucosal Drug Delivery. Int. J. Biol. Macromol. 2016;91:615-622.

    Not in our library10.1016/j.ijbiomac.2016.05.054

  12. 12.
  13. 13.

    Pillai C.K.S., Paul W., Sharma C.P. Chitin and Chitosan Polymers: Chemistry, Solubility and Fiber Formation. Prog. Polym. Sci. 2009;34:641-678.

    Not in our library10.1016/j.progpolymsci.2009.04.001

  14. 14.
  15. 15.

    Shitrit Y., Bianco-Peled H. Acrylated Chitosan for Mucoadhesive Drug Delivery Systems. Int. J. Pharm. 2017;517:247-255.

    Not in our library10.1016/j.ijpharm.2016.12.023

  16. 16.
  17. 17.

    Luo Y., Wang Q. Recent Development of Chitosan-Based Polyelectrolyte Complexes with Natural Polysaccharides for Drug Delivery. Int. J. Biol. Macromol. 2014;64:353-367.

    Not in our library10.1016/j.ijbiomac.2013.12.017

  18. 18.

    Wu D., Zhu L., Li Y., Zhang X., Xu S., Yang G., Delair T. Chitosan-Based Colloidal Polyelectrolyte Complexes for Drug Delivery: A Review. Carbohydr. Polym. 2020;238:116126.

    Not in our library10.1016/j.carbpol.2020.116126

  19. 19.
  20. 20.

    Morin-Crini N., Lichtfouse E., Torri G., Crini G. Applications of Chitosan in Food, Pharmaceuticals, Medicine, Cosmetics, Agriculture, Textiles, Pulp and Paper, Biotechnology, and Environmental Chemistry. Environ. Chem. Lett. 2019;17:1667-1692.

    Not in our library10.1007/s10311-019-00904-x

  21. 21.

    Reshad R.A.I., Jishan T.A., Chowdhury N.N. Chitosan and Its Broad Applications: A Brief Review. J. Clin. Exp. Investig. 2021;12:em00779.

    Not in our library10.29333/jcei/11268

  22. 22.

    Zou P., Yang X., Wang J., Li Y., Yu H., Zhang Y., Liu G. Advances in Characterisation and Biological Activities of Chitosan and Chitosan Oligosaccharides. Food Chem. 2016;190:1174-1181.

    Not in our library10.1016/j.foodchem.2015.06.076

  23. 23.

    Younes I., Sellimi S., Rinaudo M., Jellouli K., Nasri M. Influence of Acetylation Degree and Molecular Weight of Homogeneous Chitosans on Antibacterial and Antifungal Activities. Int. J. Food Microbiol. 2014;185:57-63.

    Not in our library10.1016/j.ijfoodmicro.2014.04.029

  24. 24.

    Hosseinnejad M., Jafari S.M. Evaluation of Different Factors Affecting Antimicrobial Properties of Chitosan. Int. J. Biol. Macromol. 2016;85:467-475.

    Not in our library10.1016/j.ijbiomac.2016.01.022

  25. 25.

    Verlee A., Mincke S., Stevens C.V. Recent Developments in Antibacterial and Antifungal Chitosan and Its Derivatives. Carbohydr. Polym. 2017;164:268-283.

    Not in our library10.1016/j.carbpol.2017.02.001

  26. 26.

    Zhengxin M., Garrido-Maestu A., Jeong K.C. Application, Mode of Action, and in Vivo Activity of Chitosan and Its Micro- and Nanoparticles as Antimicrobial Agents: A Review. Carbohydr. Polym. 2017;176:257-265.

    Not in our library10.1016/j.carbpol.2017.08.082

  27. 27.

    Chang S.H., Lin Y.Y., Wu G.J., Huang C.H., Tsai G.J. Effect of Chitosan Molecular Weight on Anti-Inflammatory Activity in the RAW 264.7 Macrophage Model. Int. J. Biol. Macromol. 2019;131:167-175.

    Not in our library10.1016/j.ijbiomac.2019.02.066

  28. 28.

    Jitprasertwong P., Khamphio M., Petsrichuang P., Eijsink V.G.H., Poolsri W., Muanprasat C., Rangnoi K., Yamabhai M. Anti-Inflammatory Activity of Soluble Chito-Oligosaccharides (CHOS) on VitD3-Induced Human THP-1 Monocytes. PLoS ONE. 2021;16:e0246381.

    Not in our library10.1371/journal.pone.0246381

  29. 29.
  30. 30.

    Fong D., Hoemann C.D. Chitosan Immunomodulatory Properties: Perspectives on the Impact of Structural Properties and Dosage. Future Sci. OA. 2018;4:FSO225.

    Not in our library10.4155/fsoa-2017-0064

  31. 31.

    Je J.Y., Kim S.K. Antioxidant Activity of Novel Chitin Derivative. Bioorg. Med. Chem. Lett. 2006;16:1884-1887.

    Not in our library10.1016/j.bmcl.2005.12.077

  32. 32.

    Zhang J., Zhang W., Mamadouba B., Xia W. A Comparative Study on Hypolipidemic Activities of High and Low Molecular Weight Chitosan in Rats. Int. J. Biol. Macromol. 2012;51:504-508.

    Not in our library10.1016/j.ijbiomac.2012.06.018

  33. 33.

    Huang L., Chen J., Cao P., Pan H., Ding C., Xiao T., Zhang P., Guo J., Su Z. Anti-Obese Effect of Glucosamine and Chitosan Oligosaccharide in High-Fat Diet-Induced Obese Rats. Mar. Drugs. 2015;13:2732-2756.

    Not in our library10.3390/md13052732

  34. 34.

    De Lima J.M., Sarmento R.R., de Souza J.R., Brayner F.A., Feitosa A.P.S., Padilha R., Alves L.C., Porto I.J. Evaluation of Hemagglutination Activity of Chitosan Nanoparticles Using Human Erythrocytes. BioMed Res. Int. 2015;2015:247965.

    Not in our library10.1155/2015/247965

  35. 35.

    Tang F., Lv L., Lu F., Rong B., Li Z., Lu B., Yu K., Liu J., Dai F., Wu D., et al. Preparation and Characterization of N -Chitosan as a Wound Healing Accelerator. Int. J. Biol. Macromol. 2016;93:1295-1303.

    Not in our library10.1016/j.ijbiomac.2016.09.101

  36. 36.

    Shen S., Chen X., Shen Z., Chen H. Marine Polysaccharides for Wound Dressings Application: An Overview. Pharmaceutics. 2021;13:1666.

    Not in our library10.3390/pharmaceutics13101666

  37. 37.

    Elgadir M.A., Uddin M.S., Ferdosh S., Adam A., Chowdhury A.J.K., Sarker M.Z.I. Impact of Chitosan Composites and Chitosan Nanoparticle Composites on Various Drug Delivery Systems: A Review. J. Food Drug Anal. 2015;23:619-629.

    Not in our library10.1016/j.jfda.2014.10.008

  38. 38.

    Shariatinia Z. Pharmaceutical Applications of Chitosan. Adv. Colloid Interface Sci. 2019;263:131-194.

    Not in our library10.1016/j.cis.2018.11.008

  39. 39.

    Mansouri S., Lavigne P., Corsi K., Benderdour M., Beaumont E., Fernandes J.C. Chitosan-DNA Nanoparticles as Non-Viral Vectors in Gene Therapy: Strategies to Improve Transfection Efficacy. Eur. J. Pharm. Biopharm. 2004;57:1-8.

    Not in our library10.1016/s0939-6411(03)00155-3

  40. 40.

    Dastidar D.G., Ghosh D. Silver Nanoparticle Decorated Chitosan Scaffoldfor Wound Healing and Tissue Regeneration. Macromolecules. 2018;105:1241-1249.

    Not in our library

All 337 references

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.